We had an amazing turnout at the CEVR Conference on 18 May 2023, with over 100 colleagues and industry partners Alcon, Menicon, and ROHTO Pharmaceutical Co., Ltd. in attendance.
Our research teams presented updates on our 5 key platforms – Myopia and Eye Growth, Ocular Drug Discovery and Delivery, Vision Enhancement, Tear Film and Ocular Surface, and Advanced Optometric Technology – showcasing the groundbreaking work we're doing.
We were thrilled to have Mr. Vincent Ma, CEO of the Hong Kong-Shenzhen Innovation and Technology Park, join us to share an overview of the park and its benefits.
We also extend our gratitude to Ms. Virginia Kwan from the Hong Kong Science and Technology Parks Corporation for introducing the Incu-Bio Programme to us.
We look forward to continuing our research and sharing our progress with you.